You are here

Prices & Quotes - UK Markets - FTSE 100 (UKX)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Down 6,898.24
Change Today:

FDA to review AstraZeneca and FibroGen's Roxadustat

By Iain Gilbert

Date: Tuesday 02 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Pharmaceutical giant AstraZeneca said on Tuesday that the Food and Drug Administration will convene a meeting of its Cardiovascular and Renal Drugs Advisory Committee to review a new US drug application for Roxadustat.
Roxadustat, AstraZeneca's collaborative effort with American firm FibroGen, has been under regulatory review for the treatment of anaemia of chronic kidney disease, with the meeting following a move by the FDA in December to extend the review period in order to carry out further analysis of data.

The drug has already been approved to treat anaemia in chronic kidney disease in non-dialysis dependent and dialysis-dependent adults patients in China, Japan and Chile and is also under regulatory review in the EU.

As of 0850 GMT, AstraZeneca shares were down 0.64% at 6,935.0p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.


Price Data

Price 6,898.24
Change Today -40.00
22-Apr-21 Close 6,938.24

Top Risers

Price Change
Intertek Group 6,244.00p +1.7%
Evraz 639.20p +1.4%
Glencore 295.85p +1.1%
Flutter Entertainment (CDI) 15,055.00p +1.0%
Just Eat Takeaway.Com N.V. (CDI) 7,929.00p +0.9%
Anglo American 3,120.50p +0.9%
Taylor Wimpey 186.35p +0.8%
Smiths Group 1,643.50p +0.8%
Ashtead Group 4,749.00p +0.8%
WPP 959.60p +0.8%

Top Fallers

Price Change
International Consolidated Airlines Group SA (CDI) 194.74p -2.9%
Next 7,832.00p -2.7%
Hargreaves Lansdown 1,660.00p -2.2%
Informa 542.20p -1.9%
Rolls-Royce Holdings 100.90p -1.9%
Hikma Pharmaceuticals 2,393.00p -1.8%
Auto Trader Group 566.60p -1.8%
JD Sports Fashion 906.80p -1.8%
Reckitt Benckiser Group 6,693.00p -1.6%
Diageo 3,264.00p -1.6%